Latest Prescription Drugs news
Merck Allows Poor Nations to Make COVID-19 Pill
posted October 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adding Interferon Beta-1a to Remdesivir No Better for COVID-19
posted October 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Belimumab Promising in Combination Therapy for Refractory Lupus
posted October 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
Lanifibranor Reduces Disease Activity in Nonalcoholic Steatohepatitis
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
